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ABSTRACT 34 
Elevating core temperature at rest causes increases in minute ventilation ( ), which leads to 35 
reductions in both arterial CO2 partial pressure (hypocapnia) and cerebral blood flow. We tested 36 
the hypothesis that in resting heated humans this hypocapnia diminishes the ventilatory 37 
sensitivity to rising core temperature but does not explain a large portion of the decrease in 38 
cerebral blood flow. Fourteen healthy men were passively heated using hot-water immersion 39 
(41°C) combined with a water-perfused suit, which caused esophageal temperature (Tes) to reach 40 
39°C. During heating in two separate trials, end-tidal CO2 partial pressure decreased from the 41 
level before heating (39.42.0 mmHg) to the end of heating (30.56.3 mmHg) (P=0.005) in the 42 
Control trial. This decrease was prevented by breathing CO2-enriched air throughout the heating 43 
such that end-tidal CO2 partial pressure did not differ between the beginning (39.81.5 mmHg) 44 
and end (40.92.7 mmHg) of heating (P=1.00). The sensitivity of  to rising Tes (i.e., slope 45 
of the Tes-  relation) did not differ between the Control and CO2-breathing trials (37.143.1 46 
vs. 16.511.1 l·min1·°C1, P=0.31). In both trials, middle cerebral artery blood velocity 47 
(MCAV) decreased early during heating (all P<0.01), despite the absence of 48 
hyperventilation-induced hypocapnia. CO2-breathing increased MCAV relative to Control at the 49 
end of heating (P=0.005) and explained 36.6% of the heat-induced reduction in MCAV. These 50 
results indicate that during passive heating at rest, ventilatory sensitivity to rising core 51 
temperature is not suppressed by hypocapnia, and that most of the decrease in cerebral blood 52 
flow occurs independently of hypocapnia.  53 
(249 words)54 
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NEW & NOTEWORTHY 55 
Hyperthermia causes hyperventilation and concomitant hypocapnia and cerebral 56 
hypoperfusion. The last may underlie central fatigue. We are the first to demonstrate that 57 
hyperthermia-induced hyperventilation is not suppressed by the resultant hypocapnia, and 58 
that hypocapnia explains only 36% of cerebral hypoperfusion elicited by hyperthermia. These 59 
new findings advance our understanding of the mechanisms controlling ventilation and 60 
cerebral blood flow during heat stress, which may be useful for developing interventions 61 
aimed at preventing central fatigue during hyperthermia.  62 
(75/75) 63 
 64 
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INTRODUCTION 66 
A rise in core temperature reportedly leads to increased minute ventilation ( ) 67 
(hyperthermic hyperventilation) at rest (10, 17, 20, 40) and during exercise (18, 33, 45, 48). 68 
Given that oxygen uptake remains largely unchanged from normothermic levels during 69 
hyperthermia in passively heated resting subjects (10, 17, 40), the influence of metabolic 70 
factors on hyperthermic hyperventilation appears to be trivial. Consequently, this 71 
hyperventilation results in excessive elimination of CO2 from the body, decreasing arterial CO2 72 
partial pressure (PaCO2) (hypocapnia) (20, 33, 40). This hypocapnia likely contributes to the 73 
cerebral hypoperfusion observed during hyperthermia (9, 16, 31, 33). By limiting heat 74 
exchange in the brain, cerebral hypoperfusion would eventually lead to elevation in brain 75 
temperature (34), which may ultimately underlie central fatigue during hyperthermia (39). 76 
Therefore, preventing the cerebral hypoperfusion associated with hyperthermic 77 
hyperventilation may be an effective strategy for minimizing central fatigue during exercise in 78 
the heat. Before implementing this strategy, however, it will be important to better understand 79 
the characteristics and underlying mechanisms of hyperthermic hyperventilation, most of 80 
which are currently unclear.  81 
When  is expressed as a function of esophageal temperature (Tes; an index of core 82 
temperature) during passive heating,  remains nearly unchanged until Tes surpasses ~37.8–83 
38.5°C (10, 17, 44). Above this threshold temperature,  increases linearly with rising Tes 84 
such that  increases by 20–32 l·min1 per 1°C rise in Tes (10, 17, 44). The slope relating Tes 85 
to  would reflect ventilatory sensitivity to rising core temperature (5, 17, 25), as it reflects 86 
the thermosensitivity of sweating and cutaneous vasodilation in those relations (7). The 87 
hyperthermic hyperventilation-induced hypocapnia potentially suppresses ventilatory 88 
sensitivity, given that ventilatory responses are highly sensitive to PaCO2 (14). Along these 89 
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lines, we previously found that during prolonged moderate exercise in the heat, continuous 90 
restoration of PaCO2 to eucapnia increased ventilatory sensitivity (24). However, it remains to 91 
be seen whether this is also true during passive heating at rest, as the characteristics of 92 
hyperthermic hyperventilation differ depending on whether one is resting or exercising (17, 44). 93 
Previous reports using passive heating at rest showed that acute restoration of end-tidal CO2 94 
partial pressure (PETCO2, an index of PaCO2) to normothermic levels did not change  at 95 
moderate hyperthermia (core temperature of ~37.6–38.0°C) (16), but it did increase  at 96 
severe hyperthermia (38.8°C) (31). The latter result lends support to the possibility that 97 
continuous maintenance of PaCO2 at eucapnia augments ventilatory sensitivity at rest. It should 98 
be emphasized that to precisely evaluate the influence of hypocapnia on the ventilatory 99 
sensitivity to rising core temperature, hypocapnia should be prevented throughout the entire 100 
period of heating, as we did previously (24). Acute restoration of eucapnia after a period of 101 
hypocapnia during heating does not enable the relationships among hypocapnia, ventilation 102 
and core temperature to be precisely characterized. 103 
As mentioned, hyperventilation-induced hypocapnia contributes to the cerebral 104 
hypoperfusion during hyperthermia. It is still debatable, however, whether this hypocapnia 105 
entirely explains the cerebral hypoperfusion during hyperthermia at rest. When PETCO2 is 106 
acutely restored to normothermic levels through CO2 inhalation during hyperthermia, the 107 
decrease in middle cerebral artery blood velocity (MCAV; an index of anterior cerebral blood 108 
flow) is partially (9, 16) or largely (3, 31) reversed. But it is well recognized that restoration of 109 
PETCO2 to eucapnia after sustained hypocapnia causes an overshoot in MCAV beyond the 110 
original baseline value (37). Thus restoration of PETCO2 after sustained hypocapnia during 111 
heating could lead to overestimation of the contribution of hypocapnia to the reduction in 112 
MCAV. To avoid that issue, it is necessary to clamp PETCO2 at a eucapnic level throughout the 113 
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passive heating, as was previously done during exercise in the heat (24). 114 
Accordingly, in the present study we examined the effect of passive heating with or 115 
without clamping PETCO2 at the eucapnic level on 1) the ventilatory sensitivity to rising core 116 
temperature and 2) the cerebral blood flow response. We hypothesized that hypocapnia 117 
developed secondary to hyperthermic hyperventilation diminishes ventilatory sensitivity and 118 
accounts for only a fraction of the reduction in cerebral blood flow.  119 
 120 
METHODS 121 
Participants 122 
Fourteen healthy males [age 24 3 years, height 173 4 cm, body mass 67 8 kg] 123 
volunteered to participate in this study. The participants were nonsmokers, and none were 124 
taking prescription medication. Written informed consent was obtained from all participants. 125 
The procedure used in this study was approved by the Human Subjects Committee of the 126 
University of Tsukuba and conformed to the provisions of the Declaration of Helsinki. 127 
 128 
Experimental Design 129 
Participants performed two trials wherein they breathed room air (Control trial) or 130 
CO2-enriched air (CO2 trial) that prevented a reduction in PETCO2 during passive heating. The 131 
two experimental trials were conducted in a counterbalanced manner and were separated by at 132 
least 7 days. Participants were asked to abstain from strenuous exercise, alcohol and caffeine 133 
for 24 h before the experiment. The participants drank 500 ml of water on the night before the 134 
experiment and then consumed a light meal and 500 ml of water 2 h prior to the experiment.  135 
 136 
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Procedure 137 
Each participant arrived at the laboratory at 9:00 a.m. and rested in an environmental 138 
chamber regulated to an ambient temperature of 25°C and a relative humidity of 50%. During 139 
this time, a thermocouple for measuring Tes was inserted through the nasal passage to a 140 
distance equivalent to one-fourth of the participant’s height. The location of the probe in the 141 
esophagus was estimated to be posterior to the lower border of the left atrium (47). The 142 
participant then voided his bladder, body mass was recorded, and an ultrasound Doppler probe 143 
for measuring MCAV was attached to the left side of his head. Thereafter, the participant was 144 
instrumented with a heart rate (HR) monitor, thermocouples for measuring skin temperatures 145 
and a cuff and electrodes for measuring arterial blood pressure. Once instrumented, the 146 
participant put on a water-perfused garment that covered his upper body with the exception of 147 
the head, left forearm and hands, which were sheathed in cotton gloves. On the left ventral 148 
forearm, a capsule for measuring sweat rate was attached using collodion and a probe for 149 
measuring skin blood flow was attached near the capsule. The participant then sat in a chair in 150 
a bath (water temperature = 35°C) immersed up to his iliac crest and rested in a sitting posture 151 
while the water from the bath was circulated through the water-perfused garment. After putting 152 
on a breathing mask, a sensor for measuring inspired and expired gases and a three-way valve 153 
customized to add CO2 to the inspired air were connected to the mask. Baseline measurements 154 
were then collected for 5 min while the subjects remained sitting. The temperature of the water 155 
in the bath, and thus the garment covering the participant’s upper body, was then increased to 156 
41°C and held constant for the remainder of the experiment. The water temperature was 157 
controlled using a heater and monitored using a thermocouple placed in the bath.  158 
In the Control trial, participants breathed room air throughout the experiment. In the 159 
CO2 trial, they breathed CO2-enriched air (a mixture of room air and 100% CO2), beginning at 160 
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the point when PETCO2 fell below baseline due to hyperthermic hyperventilation. We monitored 161 
PETCO2 on a real-time basis and manually added 100% CO2 to the inhaled air. The fraction of 162 
inspired CO2 was <3.5%. The flow rate of the added CO2 differed depending on the subject’s 163 
breathing pattern as well as the levels of  and the metabolic rate. In a preliminary 164 
experiment, 4 participants voluntarily hyperventilated such that  increased to ~20, 30 and 165 
40 l·min1 (breathing frequency (fB) of ~20, 25 and 30 breaths·min
1, respectively) with CO2 166 
supplementation to prevent hypocapnia under normothermic conditions. This experiment 167 
enabled us to roughly estimate how much CO2 we needed to add to the inspired air to prevent 168 
hypocapnia during passive heating during the CO2 trial. When Tes reached 39.0°C or the 169 
subject could no longer tolerate the heating, the experiment was terminated. 170 
 171 
Measurements 172 
Skin temperatures and Tes were measured using copper-constantan thermocouples, 173 
recorded on a computer (ThinkPad A21p, IBM, Japan) at 1-s intervals via a data logger system 174 
(WE7000, Yokogawa, Japan), and averaged over 30-s intervals. Mean skin temperature (T
 ＿
sk) 175 
was calculated from seven skin temperatures weighted to the following regional proportions: 176 
7% forehead, 14% forearm, 5% hand, 7% foot, 13% lower leg, 19% thigh and 35% chest (23). 177 
HR was recorded every 5 s using a heart rate monitor (Vantage NV, Polar, Finland) and 178 
averaged over 30-s intervals. Blood pressure was measured from the upper right arm every 1 179 
min using an automated sphygmomanometer (STBP-780, Nippon Colin, Japan). Mean arterial 180 
pressure (MAP) was calculated as the diastolic pressure plus one-third of the pulse pressure. 181 
Inspired and expired gases were analyzed using a metabolic cart (AE310s, Minato Medical 182 
Science, Japan), and , tidal volume (VT) adjusted to BTPS, fB, oxygen uptake ( 2OV ), 183 
carbon dioxide output ( 2COV ), PETCO2 and the respiratory exchange ratio were recorded 184 
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breath-by-breath. The flow sensor was calibrated using a calibration syringe able to blow a 185 
fixed volume (2 liters) of air. The O2 and CO2 sensors were calibrated with room air and 186 
reference gas of known concentration (O2 15.0%, CO2 5.0%, N2 balance). To determine MCAV, 187 
we used the transcranial Doppler ultrasound technique (WAKI 1-TC, Atys Medical, France). A 188 
2-MHz Doppler probe was secured with a customized headband to the left temporal region, 189 
and the signal was collected at a depth of 45-60 mm. Before the two experiments, the position 190 
and probe angle that provided the optimal Doppler signal were determined and photographed. 191 
The pictures enabled us to obtain similar MCAV values at baseline in the two trials. Cerebral 192 
vascular conductance (CVC) was calculated as MCAV divided by MAP. Sweat rate was 193 
measured using the ventilated-capsule method. Dry nitrogen was supplied to the capsule (3.46 194 
cm2) at a rate of 0.8 l·min1. The humidity of the nitrogen gas flowing out of the capsule was 195 
measured using a capacitance hygrometer (HMP 45ASPF, Vaisala, Finland). Cutaneous blood 196 
flow was measured using a laser-Doppler flowmeter (ALF21, Advance, Japan). Cutaneous 197 
vascular conductance was calculated as the cutaneous blood flow divided by the MAP and was 198 
normalized to the baseline value. Breathing difficulty and thermal sensation were measured 199 
every 5 min on a scale of 10 (e.g., difficulty of breathing 1: very easy, 3: moderate, 5: hard, 7: 200 
very hard; thermal sensation 5: neutral, 7: warm, 9: very hot).  201 
 202 
Data Analysis 203 
To evaluate the relationship between core temperature and ventilatory responses ( , VT, 204 
fB, and PETCO2), the ventilatory variables were plotted as functions of Tes, and linear regression 205 
analyses were conducted using 30-s averaged data. For these analyses, we used a computer 206 
algorithm to determine the thresholds for the increase or decrease in the respective ventilatory 207 
variables, as evaluated from the inflection point where two calculated regression lines crossed 208 
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(17, 44). We chose the two best-fit regression lines based on the smallest residual sums of 209 
squares. The slopes of the second regression lines relating  VT, fB and PETCO2 to Tes were 210 
considered as sensitivities. The Tes strongly correlated with  (r = 0.74 ± 0.13), VT (r = 0.53 211 
± 0.24), fB (r = 0.66 ± 0.2) and PETCO2 (r = 0.77 ± 0.20). Furthermore, we previously 212 
confirmed high day-to-day reproducibility for the Tes threshold (r = 0.83, P < 0.05) and the 213 
ventilatory sensitivity (r = 0.97, P < 0.05) of hyperthermia-induced hyperventilation (17). 214 
 215 
Statistical Analysis 216 
Two-factor repeated-measures ANOVA was used to analyze the time-dependent data 217 
using trial (Control and CO2) and heating duration (pre, 5, 10, 15, 20, 25 min and end of 218 
heating) as factors. Two-factor repeated-measures ANOVA was also employed to analyze the 219 
core temperature-dependent data using trial (Control and CO2) and Tes level (36.8, 37.2, 37.6, 220 
38.0, 38.4 and 38.8°C) as factors. When a main effect was detected, post hoc multiple 221 
comparisons were performed to identify pairwise differences using paired t-tests with the 222 
Bonferroni correction. Paired t-tests were also used for between-trial comparisons of the 223 
thresholds and sensitivities of ventilatory parameters to rising Tes. When the test of normality 224 
(Shapiro-Wilk test) failed, the Wilcoxon signed-rank test was used to assess differences 225 
between trials. All data are reported as means  SD. Values of P < 0.05 were considered 226 
significant. All statistical analyses were performed using a commercially available statistics 227 
package (version 21.0, SPSS Inc., USA). 228 
 229 
RESULTS 230 
Heating duration and body weight loss 231 
Heating duration did not differ between the trials (Control vs. CO2, 32.9  6.4 vs. 33.8  232 
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8.2 min, P = 0.58). Body mass losses over the course of the experiment were nearly identical 233 
between the Control and CO2 trials (1.5  0.5 vs. 1.4  0.5%, P = 0.20).  234 
 235 
Time-dependent changes 236 
Body temperature and thermoregulatory responses 237 
Time-dependent changes in body temperature and thermoregulatory variables are shown 238 
in Table 1 and Fig. 1A. There were main effects of trial on Tes (P < 0.01) and of heating 239 
duration on Tes and T
 ＿
sk (both P < 0.01). Over the course of the hot water immersion, Tes 240 
gradually increased, and the temperatures at the end of heating were similar in the Control and 241 
CO2 trials (38.9  0.3 vs. 39.0  0.3°C, P = 0.12). Although Tes at 5–25 min was higher in the 242 
CO2 than Control trial, the difference was minimal (<0.19°C, Fig. 1A). The rate of increase in 243 
Tes did not differ between the Control and CO2 trials (4.5  0.6 vs. 4.5  0.9°C·h
1, P = 0.81). 244 
Likewise, increases in T
 ＿
sk were equivalent during heating in the two trials. Because we were 245 
unable to measure sweat rate and cutaneous blood flow on the forearms of three subjects due to 246 
technical difficulties, the data analyzed were from the remaining 11 subjects. Forearm sweat 247 
rate and cutaneous vascular conductance did not differ between trials (P = 0.52 and 0.68 for a 248 
main effect of trial, respectively), and thermal sensation increased similarly in the two trials (P 249 
= 0.29 for a main effect of trial). 250 
Cardiovascular and cerebrovascular responses 251 
Similar changes in HR and MAP were observed in the two trials (P = 0.25 and 0.99 for a 252 
main effect of trial, respectively, Table 1). There was a significant interaction between trial and 253 
heating duration affecting MCAV and CVC (both P < 0.05). In both trials, MCAV was 254 
decreased at and after 10 min of heating in comparison to the pre-heating value. In addition, 255 
MCAV was higher in the CO2 than Control trial at the end of heating (P = 0.005, Fig. 1D), and 256 
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explains 36.6% of the total decrease in MCAV occurring in the Control trial. The changes in 257 
CVC were similar to those observed with MCAV, and CVC was higher in the CO2 than 258 
Control trial at the end of heating (P = 0.014, Table 1). 259 
Ventilatory responses 260 
Time-dependent changes in respiratory variables are shown in Table 2 and Fig. 1B and C. 261 
A significant main effect of heating duration was detected on all the respiratory variables 262 
evaluated (all P < 0.01). Similar increases in  were observed in the two trials (P = 0.52 for 263 
a main effect of trial). From pre-heating to 15 min of heating,  increased slightly, and then 264 
increased as heating continued (at the end of heating, 23.8  8.3 and 22.9  7.3 l·min1 in the 265 
Control and CO2 trial, respectively, Fig. 1B). Both VT and fB did not differ between trials (P = 266 
0.31 and 0.37 for a main effect of trial, respectively). At the end of heating in the Control trial, 267 
PETCO2 was significantly lower than before heating. As designed, PETCO2 in the CO2 trial 268 
remained unchanged over the period of heating, and was higher than in the Control trial after 269 
15 min of heating (Fig. 1C).  270 
 271 
Tes-dependent changes in ventilatory and cerebrovascular responses 272 
Figure 2 shows  plotted against Tes. The thresholds and sensitivities of the 273 
relationships between ventilatory variables and Tes are presented in Tables 3 and 4. Twelve of 274 
the 14 subjects showed Tes thresholds for increases in  in both trials. One subject showed 275 
no threshold in either trial, and another subject exhibited no threshold in the CO2 trial only. 276 
There was no significant between-trial difference in the threshold (P = 0.15). We also observed 277 
Tes thresholds for increases in VT in 8 subjects and for increases in fB in 11 subjects in both 278 
trials, and for decreases in PETCO2 in 13 subjects in the Control trial. There were no significant 279 
between-trial differences in the thresholds for VT or fB (P = 0.06 and 0.56, respectively).  280 
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Individual data for the sensitivities of ventilatory responses to rising Tes are shown in 281 
Table 4. In 4 of 12 subjects, the sensitivity of  to rising Tes was higher in the CO2 than the 282 
Control trial. The sensitivities of VT and fB to rising Tes were higher in the CO2 than the Control 283 
trial in 3 of 8 subjects and in 3 out of 11 subjects, respectively. There were no between-trial 284 
differences in the sensitivities of , VT and fB to rising Tes (P = 0.31, 0.11 and 0.86, 285 
respectively). Although there was a two-fold between-trial difference in the mean value of the 286 
sensitivity of , this difference largely disappeared when 2 outliers were excluded (subjects 287 
#4 and #9), resulting in similar mean values in the two trials (Control vs. CO2 trial: 19.6 ± 14.8 288 
vs. 17.6 ± 11.9 l·min1·°C1, respectively). 289 
Ventilatory and cerebrovascular responses were compared between trials at various Tes 290 
(Figs. 3 and 4). There were main effects of Tes on , VT, PETCO2 and MCAV (all P < 0.01). 291 
The increase in  and the respiratory pattern, as evaluated based on VT and fB, were similar 292 
in the Control and CO2 trials (P = 0.28, 0.74 and 0.18 for a main effect of trial, respectively, 293 
Fig. 3). In the Control trial, PETCO2 was lower at Tes = 38.8°C than 36.8°C, but it remained 294 
unchanged in the CO2 trial. A main effect of trial on PETCO2 was detected. At Tes = 37.6–38.8°C, 295 
PETCO2 was higher in the CO2 than Control trial (all P < 0.01, Fig. 4A). There was no main 296 
effect of trial on MCAV (P = 0.30). In both trials, MCAV was lower at Tes = 37.2–38.8°C than 297 
36.8°C (Fig. 4B). In the CO2 trial, restoration of the PETCO2 restored 37.6%, 39.8% and 39.3% 298 
of the heating-induced decrease in MCAV in the Control trial at Tes = 38.0, 38.4 and 38.8°C, 299 
respectively. 300 
 301 
DISCUSSION 302 
Our main findings are that during passive heating at rest, 1) the sensitivity of  to 303 
rising Tes did not differ between the Control and CO2 trials; 2) the decrease in MCAV occurred 304 
EV
EV
EV
EV
EV
EV
 by 10.220.33.6 on O
ctober 5, 2017
http://jap.physiology.org/
D
ow
nloaded from
 
14 
 
early during heating, when there was no clear hyperventilation or resultant hypocapnia; 3) at 305 
the end of heating (Tes = 39.0), MCAV was significantly higher in the CO2 than Control trial, 306 
but hypocapnia explained only 36.6% of the observed reduction in MCAV. These results 307 
suggest that during passive heating at rest, ventilatory sensitivity to rising core temperature is 308 
not suppressed by the resultant hypocapnia, and that hyperthermia decreases cerebral blood 309 
flow largely independently of the concomitant hypocapnia.  310 
 311 
Effect of hypocapnia on ventilatory sensitivity to rising core temperature 312 
Contrary to our hypothesis, the sensitivity of  to rising Tes was not greater in the CO2 313 
trial than the Control trial (Fig. 2 and Table 4). Only 4 of 12 subjects showed a higher 314 
sensitivity in the CO2 trial; the others showed somewhat lower sensitivity in the CO2 than 315 
Control trial. Similarly,  at similar Tes levels did not differ between the trials (Fig. 3A). 316 
These results suggest that for subjects in a hyperthermic resting state, hypocapnia does not 317 
suppress ventilatory sensitivity to rising core temperature. By contrast, we previously reported 318 
that, during prolonged moderate-intensity exercise in the heat, restoration of PaCO2 to the 319 
eucapnic level led to a doubling of ventilatory sensitivity as compared to the sensitivity when 320 
PaCO2 was decreased secondary to hyperthermic hyperventilation (19.8 vs. 8.9 l·min
1·°C1) 321 
(24). We therefore suggest that hypocapnia diminishes ventilatory sensitivity during exercise 322 
but not at rest. Furthermore, the fact that hypocapnia attenuates hyperthermic hyperventilation 323 
only during exercise likely contributes to the approximately three-times smaller ventilatory 324 
sensitivity to rising core temperature observed during exercise in the heat as compared to 325 
resting (17, 44).  326 
The lack of change in ventilatory sensitivity upon PaCO2 restoration may be due to the 327 
location of the PaCO2 threshold for increases in . The threshold exists at a normal PaCO2 328 
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level at rest (4, 14), and  remains unchanged when PaCO2 decreases below the threshold. 329 
This PaCO2 threshold is also reportedly unaffected by a 1.5°C elevation in core temperature at 330 
rest (4, 6). Because hyperthermic hyperventilation during passive heating decreases PaCO2 331 
below normal level, it is plausible that these changes in PaCO2 are below the threshold for 332 
increases in  and so did not affect hyperthermic hyperventilation at rest. On the other hand, 333 
although the PaCO2 threshold for increases in  is reportedly similar during rest and 334 
exercise (11, 13), as mentioned, we previously found that  increased with restoration of 335 
PaCO2 to the eucapnic level during exercise in the heat (24). This implies that exercise in 336 
combination with hyperthermia shifts the PaCO2 threshold to lower PaCO2 levels than that at 337 
rest.  338 
We previously observed that acute restoration of PETCO2 to eucapnia does not influence 339 
 at Tes = 37.6 or 38.0°C (16). However, similar restoration increased  at a higher Tes 340 
(i.e., 38.7 °C) (3). In addition, restoration of normocapnia reportedly decreased  at a rectal 341 
temperature of 39.1°C (39), though the level of hyperthermia should be regarded with caution, 342 
as rectal temperature responds more slowly than Tes (42). The reason for these disparate results 343 
remains unclear. Because we detected no effect of hypocapnia on , irrespective of core 344 
temperature in the present study (Fig. 4A), different core temperatures would not explain the 345 
lack of consistency between studies. Other differences such as posture (upright (16, 39) versus 346 
supine (3)) might be involved, but that remains to be determined.  347 
 348 
Effect of hypocapnia on the cerebrovascular response to rising core temperature 349 
With rising Tes in the present study, MCAV in the Control trial decreased to levels below 350 
the pre-heating baseline, which is in line with previous studies (9, 16, 29, 31). Early during the 351 
heating, MCAV decreased compared to baseline in both trials, despite hyperthermic 352 
EV
EV
EV
EV
EV EV
EV
EV
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hyperventilation, and thus resultant hypocapnia, being minimal (Fig. 1C and D). This implies 353 
that at rest hyperthermia can decrease cerebral blood flow independently of hypocapnia. When 354 
the decrease in PETCO2 was prevented in the CO2 trial, MCAV was higher than in the Control 355 
trial during the latter part of heating (Fig. 1C); however, the restoration accounts for only 356 
36.6% of total decrease in MCAV (Fig. 1D). Hence, although hypocapnia appears to contribute 357 
to the decrease in cerebral blood flow during passive heating at rest, a larger portion of the 358 
response is explained by one or more hypocapnia-independent factors. Furthermore, MCAV 359 
was similarly restored by 40% across the range of Tes = 38.0–38.8°C (Fig. 4B), indicating that 360 
the relative contribution of hypocapnia to the change in cerebral blood flow during passive 361 
heating is similar within this temperature range.  362 
Previous studies reported that restoration of PETCO2 through acute CO2 inhalation during 363 
passive heating increased MCAV by ~28% and ~38% at core temperatures of 37.6°C and 364 
38.0°C, respectively (16) and increased MCAV by ~50% at a core temperature of 38.5°C (9). 365 
By contrast, the restoration of PETCO2 reversed reductions in MCAV and posterior cerebral 366 
artery blood flow velocity by ~67% and ~84%, respectively, at core temperature of 38.8°C (31), 367 
and it increased MCAV by ~75% at a core temperature of 38.7°C (3). It is however noteworthy 368 
that the all the results shown above could be influenced by prolonged exposure of hypocapnia, 369 
during which MCAV gradually increased despite the sustained hypocapnic state as a result of 370 
reductions in brain extracellular bicarbonate and recovery of extracellular pH (8). 371 
Consequently, restoration of PaCO2 to a eucapnic level after prolonged hypocapnic exposure 372 
produces an overshoot in MCAV above baseline values (27, 37). We suggest that the different 373 
magnitudes of this adaptation, in addition to the postural difference as speculated by Bain et al. 374 
(2), may underlie the discrepancy among the earlier studies.  375 
The mechanism underlying hypocapnia-independent decrease in MCAV during heat 376 
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stress is unclear. Because there was no decrease in MAP throughout the heating in the present 377 
study, the possibility of decreased cerebral perfusion pressure is excluded. On the other hand, 378 
blood distribution to the internal carotid artery, from which the MCA branches, reportedly 379 
decreases, possibly due to an increase in blood distribution to the external carotid artery, which 380 
supplies blood to the cutaneous vessels of the head for thermoregulation (35). Furthermore, 381 
blood flow in the internal carotid artery gradually decreases with rising Tes (35). Thus, 382 
modification of the blood distribution in the brain during passive heating may explain the 383 
hypocapnia-independent reduction in MCAV. In addition, cerebral vessels are innervated by 384 
nerve fibers that originate from peripheral (extrinsic) nerve ganglia and intrinsic nerves (22). In 385 
humans, stellate ganglion blockade increases cerebral blood flow (26, 46), suggesting 386 
regulation of cerebral blood flow is associated with sympathetic nerve activity. Given that 387 
hyperthermia increases skin and muscle sympathetic nerve activities (28), cerebral 388 
vasoconstriction during hyperthermia may be due in part to sympathetic vasoconstriction, as 389 
previously speculated by Brothers et al. (9).  390 
 391 
Effect of hypocapnia on other variables 392 
In our earlier study, which employed the same heating protocol (19), we showed that 393 
greater hyperthermic hyperventilation correlates with lower MAP. This implies that 394 
hyperthermic hyperventilation may lower MAP during passive heating at rest. In the present 395 
study, however, MAP did not differ between the Control and CO2 trials (Table 1), indicating 396 
that hypocapnia does not influence MAP during passive heating at rest. Hence hyperventilation 397 
itself might decrease MAP during passive heating at rest. This notion is indirectly supported by 398 
the earlier finding that lung inflation decreases MAP (36). 399 
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There were no between-trial differences in forearm sweat rate or cutaneous vascular 400 
conductance (Table 1), which suggests hypocapnia does not influence sweating or cutaneous 401 
blood flow during passive heating at rest. This is in contrast to the previous observations made 402 
by Albert (1), Robinson and King (38) and Fujii et al. (15). The discrepancy may reflect 403 
differences in core temperature. For example, Fujii et al. (15) reported that hypocapnia reduced 404 
forearm cutaneous blood flow when Tes increased by 0.6°C but not 1.0°C. Since hyperthermic 405 
hyperventilation and resultant hypocapnia during passive heating occurred with increases in Tes 406 
of ~1.01.5°C, as shown in that study, it is plausible that the greater elevation in core 407 
temperature masked the hypocapnia-induced suppression of cutaneous blood flow. Whether the 408 
same explanation applies to the sweat response remains to be investigated.  409 
 410 
Limitations 411 
Coverdale et al. (12) recently reported that MCA diameter measured using magnetic 412 
resonance imaging decreased by 4% when PETCO2 decreased from 36 to 23 mmHg, which is in 413 
contrast to previous reports that MCA diameter is unaffected by decreases in PETCO2 to ~25 414 
mmHg (21, 41). It may thus be possible that the degree to which MCAV was reduced in the 415 
Control trial underestimated the true degree to which MCA blood flow was reduced, as blood 416 
flow was actually decreased farther than was reflected by the change in velocity.   417 
 418 
Perspectives and significance 419 
Reduced cerebral blood flow during hyperthermia reportedly leads to increased brain 420 
temperature (34) and central fatigue (39) without modulating cerebral metabolism (32, 43). 421 
The present study demonstrated that hypocapnia induced through hyperventilation does not 422 
modulate ventilatory responses to rising core temperature, but does contribute to the decrease 423 
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in cerebral blood flow seen during passive heating at rest. Based on this observation, we 424 
speculate that restoration of normocapnia by inhaling CO2 gas is not sufficient to fully restore 425 
cerebral perfusion during passive heating at rest, and a hypercapnic state (i.e., increase in 426 
arterial CO2 pressure above normocapnic level) or other countermeasures, such as whole-body 427 
skin cooling (30), may be required to prevent cerebral hypoperfusion. Furthermore, we found 428 
that inhaling CO2 gas to prevent hypocapnia during passive hyperthermia does not induce 429 
additional hyperventilation or dyspnea, as evaluated based on difficulty of breathing. This is in 430 
stark contrast to what was observed during exercise in the heat, wherein preventing hypocapnia 431 
by inhaling CO2 gas increased ventilation (24). Therefore, although inhaling CO2 gas can 432 
reverse cerebral hypoperfusion, irrespective of whether the subjects are resting or exercising, 433 
this maneuver can distress the respiratory system during exercise. This is important 434 
information to know when employing CO2 gas inhalation as a strategy to mitigate cerebral 435 
hypoperfusion during heat stress. 436 
 437 
Conclusion 438 
In summary, our results suggest that the ventilatory sensitivity to rising core temperature 439 
is not suppressed by hypocapnia, and that hyperthermia decrease cerebral blood flow largely 440 
independently of the hypocapnia during passive heating at rest. 441 
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FIGURE LEGEND 579 
Figure 1. Time-dependent changes in esophageal temperature (A), minute ventilation (B), 580 
end-tidal CO2 pressure (PETCO2; C) and middle cerebral artery blood velocity (MCAV; D) 581 
during passive heating in the Control and CO2 trials. *P < 0.05, Control vs. CO2; †P < 0.05, vs. 582 
pre-heating (Pre) in the Control trial; ‡P < 0.05, vs. Pre in the CO2 trial. Symbols are means  583 
SD (n = 14). 584 
 585 
Figure 2. Esophageal temperature-dependent changes in minute ventilation during passive 586 
heating in the Control and CO2 trials. Symbols show 30-s averaged data. Arrows (dashed: 587 
Control; solid: CO2) show the averaged esophageal temperature threshold. 588 
 589 
Figure 3. Esophageal temperature-dependent changes in minute ventilation (A), tidal volume 590 
(B) and breathing frequency (C) during passive heating in the Control and CO2 trials. †P < 591 
0.05, vs. 36.8°C in the Control trial; ‡P < 0.05, vs. 36.8°C in the CO2 trial. Symbols are means 592 
 SD (n = 14). The numbers adjacent to the symbols in the Control trial indicate the number of 593 
subjects remaining at the corresponding temperature.  594 
 595 
Figure 4. Esophageal temperature-dependent changes in PETCO2 (A) and MCAV (B) during 596 
passive heating in the Control and CO2 trials. *P < 0.05, Control vs. CO2; †P < 0.05, vs. 597 
36.8°C in the Control trial; ‡P < 0.05, vs. 36.8°C in the CO2 trial. Symbols are means  SD (n 598 
= 14). The numbers adjacent to the symbols in the Control trial indicate the number of subjects 599 
remaining at the corresponding temperature. 600 
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Table 1. Time-dependent changes in body temperature and thermoregulatory and circulatory 601 
variables during passive heating 602 
 603 
Values are means  SD. n = 14 except for sweat rate, cutaneous vascular conductance and 604 
thermal sensation. *P < 0.05 vs. Control trial; †P < 0.05 vs. pre-heating (pre) in the Control 605 
trial; ‡P < 0.05 vs. pre in the CO2 trial.606 
Mean skin temperature, °C
              Control trial 34.7  0.6 35.7  0.8† 37.5  0.7† 37.9  0.7† 38.1  0.7† 38.3  0.7† 38.4  0.9†
              CO2 trial 34.8  0.4 35.8  0.6‡ 37.6  0.7‡ 38.0  0.7‡ 38.2  0.6‡ 38.4  0.6‡ 38.5  0.5‡
Forearm sweat rate, mg∙cm2∙min1 (n  = 11)
              Control trial 0.0  0.0 0.1  0.1 0.4  0.3† 0.8  0.4† 1.0  0.4† 1.1  0.4† 1.1  0.4†
              CO2 trial 0.0  0.0 0.1  0.1 0.5  0.2‡ 0.9  0.4‡ 1.0  0.4‡ 1.1  0.4‡ 1.1  0.4‡
Forearm cutaneous vascular conductance, %baseline (n  = 11)
              Control trial 100  0 124  37 295  141† 410  253† 434  291 442  298 444  298
              CO2 trial 100  0 131  50 375  251 456  309 470  301‡ 467  283‡ 482  282‡
Thermal sensation (n  = 12)
              Control trial  6.3  2.0 7.3  2.1 7.9  1.6† 8.2  1.2† 8.8  1.0† 9.2  1.1†
              CO2 trial  7.0  1.0 7.8  0.9‡ 8.1  0.7‡ 8.4  0.8‡ 9.0  0.4‡ 9.3  0.7‡
Heart rate, beats∙min1
              Control trial 66  10 71  12† 89  14† 101  14† 109  15† 118  18† 128  17†
              CO2 trial 66  9 73  9‡ 93  11‡ 105  13‡ 114  15‡ 121  16‡ 130  15‡
Mean arterial pressure, mmHg
              Control trial 85  7 87  6 87  5 88  6 88  6 90  6 90  6
              CO2 trial 83  7 87  7 86  8‡ 88  8 90  8‡ 91  7‡ 91  7‡
Cerebral vascular conductance, cm∙s-1∙mmHg-1
              Control trial 0.76  0.11 0.74  0.12 0.68  0.12† 0.63  0.11† 0.62  0.12† 0.58  0.14† 0.53  0.14†
              CO2 trial 0.78  0.11 0.74  0.10‡ 0.69  0.11‡ 0.66  0.09‡ 0.63  0.09‡ 0.61  0.08‡ 0.59  0.09*‡
end of heatingpre 5min 10 min 25 min20 min15 min
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Table 2. Time-dependent changes in respiratory variables during passive heating 607 
 608 
Values are means  SD. n = 14. *P < 0.05 vs. Control trial; †P < 0.05 vs. pre-heating (pre) in 609 
the Control trial; ‡P < 0.05 vs. pre in the CO2 trial.610 
Tida volume, ml
              Control trial 630  114 633  98 704  126† 778  155† 875  261 936  261† 1050  274†
              CO2 trial 658  103 644  70 670  77 773  130 947  268‡ 996  263‡ 1080  217‡
Breathing frequency, breaths∙min1
              Control trial 17  3 19  3† 19  4 17  4 17  4 20  5 23  6†
              CO2 trial 17  4 19  3‡ 20  4‡ 18  7 18  6 19  6 23  8
Oxygen uptake, ml∙min1
              Control trial 252  41 270  35 290  29† 315  36† 338  34† 361  39† 399  53†
              CO2 trial 265  29 279  28‡ 291  35‡ 324  40‡ 347  37‡ 361  33‡ 372  28‡
Carbon dioxide output, ml∙min1
              Control trial 212  39 235  32 272  31† 299  45† 327  55† 371  80† 453  93†
              CO2 trial 220  25 243  26‡ 267  33‡ 293  35‡ 320  49‡ 322  44*‡ 340  49*‡
Respiratory exchange ratio, units
              Control trial 0.84  0.03 0.87  0.04† 0.94  0.04† 0.95  0.06† 0.96  0.11† 1.02  0.18 1.12  0.22
              CO2 trial 0.83  0.05 0.87  0.04‡ 0.92  0.04‡ 0.90  0.06‡ 0.92  0.08‡ 0.88  0.07*‡ 0.91  0.10*‡
Difficulty of breathing
              Control trial  1.6  1.1 2.6  1.6 3.5  2.2† 4.3  2.2† 5.2  2.5† 6.2  2.2†
              CO2 trial  1.9  1.0 2.7  1.4‡ 3.8  1.7‡ 4.6  2.5‡ 5.6  2.6‡ 6.7  2.2‡
pre 5min 10 min 15 min 20 min 25 min end of heating
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Table 3. Core temperature thresholds of the indicated ventilatory parameters to rising 611 
esophageal temperature  612 
 613 
Values are means  SD (95% confidence interval). For data analysis, we did not include a 614 
subject who did not exhibit a clear core temperature threshold to the relevant ventilatory 615 
variable. As a result, the number of subjects was 12, 8, 11 and 13 for minute ventilation, tidal 616 
volume, respiratory frequency and end-tidal CO2 pressure, respectively.617 
Minute ventilation 38.4  0.4 (38.138.6) 38.1  0.6 (37.738.5)
Tidal volume 38.4 ± 0.5 (37.938.8) 37.7 ± 0.9 (36.938.4)
Respiratory frequency 38.1  0.6 (37.738.5) 38.3  0.5 (37.938.6)
End-tidal CO2 pressure 38.2  0.5 (37.938.5) ―
Control CO2
Threshold, °C
 by 10.220.33.6 on O
ctober 5, 2017
http://jap.physiology.org/
D
ow
nloaded from
 
29 
 
Table 4. Individual sensitivities of the indicated ventilatory parameters to increasing 618 
esophageal temperature 619 
 620 
Values are means  SD. , minute ventilation; VT, tidal volume; fB, breathing frequency;  621 
PETCO2, end-tidal CO2 partial pressure. 622 
Subject Control CO2 Control CO2 Control CO2 Control CO2
1 7.9 13.5   5.2 21.4 -1.1 
2 45.2 42.0 988 293 35.1 33.9 -39.5 
3 19.3 12.3 897 483 7.8 5.9 -16.7 
4 119.1 12.9 56 285 26.5 8.7 -70.4 
5 8.8 17.1 147 342 10.1 7.7 -12.3 
6 6.7 29.2 95 270 3.5 66.2 -5.1 
7 20.5 27.9   37.1 8.2 -16.6 
8 30.1 10.2 727 133 11.3 21.4 -21.0 
9 130.2 8.5   27.8 4.2 -31.1 
10 7.4 5.7   9.1 1.4 -5.2 
11 8.1 4.5 719 424   -2.2 
12 42.1 13.6 1329 448 27.7 4.3 -53.7 
Mean 37.1  43.1 16.5  11.1 620  471 335  115 18.3  12.6 16.7  19.2 -21.9  21.3 
P  value
VE, l∙min
-1∙°C-1 VT, ml∙°C
-1
f B, breaths∙min
-1∙°C-1 PETCO2, Torr∙°C
-1
0.31 0.11 0.86 
·
·
EV
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